Compare TDG & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TDG | COR |
|---|---|---|
| Founded | 1993 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Other Pharmaceuticals |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.4B | 68.5B |
| IPO Year | 2005 | 2001 |
| Metric | TDG | COR |
|---|---|---|
| Price | $1,175.91 | $320.39 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 13 |
| Target Price | ★ $1,559.69 | $395.23 |
| AVG Volume (30 Days) | 395.4K | ★ 1.4M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | ★ 7.57% | 0.75% |
| EPS Growth | ★ 25.21 | 5.71 |
| EPS | ★ 6.62 | 2.87 |
| Revenue | $8,831,000,000.00 | ★ $321,332,819,000.00 |
| Revenue This Year | $14.58 | $8.91 |
| Revenue Next Year | $8.11 | $6.84 |
| P/E Ratio | $179.39 | ★ $111.50 |
| Revenue Growth | ★ 11.22 | 9.31 |
| 52 Week Low | $1,123.61 | $269.37 |
| 52 Week High | $1,623.83 | $377.54 |
| Indicator | TDG | COR |
|---|---|---|
| Relative Strength Index (RSI) | 41.38 | 39.91 |
| Support Level | N/A | $287.38 |
| Resistance Level | $1,348.76 | $353.18 |
| Average True Range (ATR) | 32.66 | 8.49 |
| MACD | 5.59 | 0.24 |
| Stochastic Oscillator | 47.82 | 46.94 |
TransDigm manufactures and services a broad set of specialized parts for commercial and military aircraft. The firm organizes itself in three segments: power and control, airframes, and a small non-aviation segment, which serves mostly off-road vehicles and mining equipment. It operates as an acquisitive holding company that focuses on buying up smaller firms that make proprietary aerospace products with substantial aftermarket demand. TransDigm regularly employs financial leverage to amplify its operating results.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.